Most interesting. There are even easier and more direct ways to improve resistance to glaucoma; namely high dose nictotinamide (aka niacinamide aka non-flushing vitamin B3, aka NAM).

The key paper was published in Science in 2017 by Pete Williams, Simon John and colleagues in mice.

https://pubmed.ncbi.nlm.nih.gov/28209901/

Vit B3 at relatively high dose (1 to 4 gm/day) is now being tested in several human clinical trials for glaucoma and other forms of neurodegenerative and neurocognitive age-related diseases.

See ClinicalTrsil.giv

https://clinicaltrials.gov/ct2/results?cond=Glaucoma&term=ni...

Results are promising, but like most therapeutics the efficacy is likely to vary by genotype, disease subtype, age, diet etc.

I’ve been taking 3 g/day for 6 years and have noticed improvements in cognitive function (recall, speech speed). But I freely admit that this could be placebo effect or due to weight loss and more exercise, so take my n=1 uncontrolled trial with big grain of salt.